PriceTargets.com logo

Lemonade - LMND Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $18.86
  • Forecasted Upside: 4.94%
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$17.97 As of 05/17/2024 01:00 AM ET
▲ +0.27 (1.53%)

This chart shows the closing price for LMND by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Lemonade Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LMND and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LMND

Analyst Price Target is $18.86
▲ +4.94% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Lemonade in the last 3 months. The average price target is $18.86, with a high forecast of $40.00 and a low forecast of $9.00. The average price target represents a 4.94% upside from the last price of $17.97.

This chart shows the closing price for LMND for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 contributing investment analysts is to reduce stock in Lemonade. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
11/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
5/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
8/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
11/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
2/19/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
4/19/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
5/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2024Jefferies Financial GroupBoost TargetUnderperform ➝ Underperform$14.00 ➝ $16.00Low
5/2/2024Piper SandlerBoost TargetNeutral ➝ Neutral$17.00 ➝ $18.00Low
4/15/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$40.00Low
3/4/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$16.00 ➝ $18.00Low
2/29/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$17.00Low
2/28/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$13.00 ➝ $14.00Low
1/10/2024TD CowenInitiated CoverageMarket Perform$17.00Low
12/1/2023OppenheimerReiterated RatingOutperform ➝ Market PerformLow
11/2/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$10.00 ➝ $11.00N/A
10/11/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$15.00 ➝ $10.00Low
10/6/2023Jefferies Financial GroupLower Target$14.00 ➝ $10.00Low
9/28/2023BMO Capital MarketsBoost TargetUnderperform ➝ Underperform$8.00 ➝ $9.00Low
8/4/2023Piper SandlerLower TargetNeutral ➝ Neutral$18.00 ➝ $17.00Low
8/3/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$14.00 ➝ $15.00Low
6/20/2023Morgan StanleyInitiated CoverageUnderweight$14.00Low
5/9/2023BarclaysBoost Target$16.00 ➝ $17.00Low
5/4/2023Bank of AmericaLower Target$14.00 ➝ $12.00Low
4/10/2023Jefferies Financial GroupLower TargetUnderperform$13.00 ➝ $11.50Low
2/24/2023Piper SandlerLower TargetNeutral$19.00 ➝ $18.00Low
2/24/2023BarclaysLower TargetEqual Weight$18.00 ➝ $16.00Low
1/19/2023BMO Capital MarketsInitiated CoverageUnderperform$10.00Low
1/18/2023Piper SandlerLower TargetNeutral$20.00 ➝ $19.00Low
11/17/2022Keefe, Bruyette & WoodsInitiated CoverageMarket Perform$24.00Low
11/15/2022OppenheimerLower Target$30.00Low
11/10/2022Piper SandlerLower TargetNeutral$25.00 ➝ $20.00Low
11/10/2022BarclaysLower TargetEqual Weight$28.00 ➝ $18.00Low
8/10/2022OppenheimerBoost Target$30.00 ➝ $35.00Low
8/10/2022BarclaysBoost TargetEqual Weight$20.00 ➝ $28.00Low
8/10/2022Piper SandlerBoost TargetNeutral$20.00 ➝ $25.00Low
7/22/2022Credit Suisse GroupLower Target$14.00Low
7/18/2022Piper SandlerDowngradeOverweight ➝ Neutral$24.00 ➝ $20.00Low
5/11/2022OppenheimerLower Target$45.00 ➝ $30.00High
5/11/2022JMP SecuritiesLower Target$95.00 ➝ $40.00High
3/4/2022Morgan StanleyLower TargetEqual Weight$74.00 ➝ $28.00High
2/25/2022BarclaysLower Target$43.00 ➝ $22.00Medium
2/25/2022OppenheimerLower TargetOutperform$85.00 ➝ $45.00Low
2/25/2022Piper SandlerLower TargetOverweight$54.00 ➝ $32.00Low
1/13/2022Piper SandlerLower TargetOverweight$84.00 ➝ $54.00High
1/6/2022BarclaysLower TargetEqual Weight$62.00 ➝ $43.00High
11/18/2021Jefferies Financial GroupInitiated CoverageUnderperform$49.00Medium
11/10/2021OppenheimerLower TargetOutperform$95.00 ➝ $85.00Low
11/10/2021JMP SecuritiesLower TargetOutperform$130.00 ➝ $95.00Low
11/10/2021BarclaysLower TargetEqual Weight$68.00 ➝ $62.00Low
10/19/2021BarclaysLower TargetEqual Weight$80.00 ➝ $68.00High
10/15/2021Morgan StanleyLower TargetEqual Weight$90.00 ➝ $74.00High
8/16/2021Wolfe ResearchInitiated CoverageUnderperform$53.00High
8/6/2021OppenheimerBoost TargetOutperform$85.00 ➝ $95.00Low
8/6/2021Piper SandlerLower TargetOverweight$103.00 ➝ $98.00Low
5/13/2021BarclaysLower TargetEqual Weight$101.00 ➝ $71.00High
3/30/2021Piper SandlerLower TargetOverweight$159.00 ➝ $134.00High
3/9/2021Bank of AmericaInitiated CoverageUnderperform$29.00High
3/8/2021OppenheimerUpgradeMarket Perform ➝ Outperform$110.00Medium
3/3/2021JMP SecuritiesBoost TargetOutperform$105.00 ➝ $130.00High
1/21/2021Piper SandlerBoost TargetOverweight$105.00 ➝ $163.00Low
1/12/2021Morgan StanleyBoost TargetEqual Weight$70.00 ➝ $90.00High
12/16/2020Piper SandlerBoost TargetOverweight$71.00 ➝ $105.00N/A
11/12/2020Piper SandlerBoost TargetOverweight$63.00 ➝ $71.00High
11/2/2020Piper SandlerInitiated CoverageOverweight$63.00High
10/15/2020Credit Suisse GroupInitiated CoverageUnderperform$56.00High
8/14/2020Morgan StanleyLower TargetEqual Weight$91.00 ➝ $70.00High
7/27/2020OppenheimerReiterated RatingMarket PerformHigh
7/27/2020The Goldman Sachs GroupInitiated CoverageSellHigh
7/27/2020BarclaysInitiated CoverageEqual Weight$83.00High
7/27/2020JMP SecuritiesInitiated CoverageOutperform$105.00High
7/27/2020William BlairInitiated CoverageMarket PerformHigh
7/27/2020Morgan StanleyInitiated CoverageEqual Weight$91.00High
(Data available from 5/19/2019 forward)

News Sentiment Rating

0.50 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 6 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024
  • 6 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2024

Current Sentiment

  • 6 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Lemonade logo
Lemonade, Inc. provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, car, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Read More

Today's Range

Now: $17.97
Low: $17.41
High: $18.08

50 Day Range

MA: $16.89
Low: $15.67
High: $18.92

52 Week Range

Now: $17.97
Low: $10.27
High: $24.81

Volume

1,317,411 shs

Average Volume

1,784,058 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Lemonade?

The following Wall Street sell-side analysts have issued stock ratings on Lemonade in the last twelve months: BMO Capital Markets, Jefferies Financial Group Inc., JMP Securities, Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, and TD Cowen.
View the latest analyst ratings for LMND.

What is the current price target for Lemonade?

7 Wall Street analysts have set twelve-month price targets for Lemonade in the last year. Their average twelve-month price target is $18.86, suggesting a possible upside of 4.9%. JMP Securities has the highest price target set, predicting LMND will reach $40.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $9.00 for Lemonade in the next year.
View the latest price targets for LMND.

What is the current consensus analyst rating for Lemonade?

Lemonade currently has 3 sell ratings, 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for LMND.

What other companies compete with Lemonade?

Other companies that are similar to Lemonade include Horace Mann Educators, Skyward Specialty Insurance Group, Safety Insurance Group, Employers and HCI Group. Learn More about companies similar to Lemonade.

How do I contact Lemonade's investor relations team?

Lemonade's physical mailing address is 5 CROSBY STREET 3RD FLOOR, NEW YORK NY, 10013. The company's listed phone number is 844-733-8666 and its investor relations email address is [email protected]. The official website for Lemonade is www.lemonade.com. Learn More about contacing Lemonade investor relations.